Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
International Council for Harmonisation (ICH) Health Canada role in ICH ICH consultations Guidelines Draft ICH documents for consultation Table 1 Footnote * Document Type of Notice File Number Consultation Start Date Consultation End Date Release of draft (step 2) ICH E22:…
Notice: Confirmation of the Mandatory use of the Regulatory Enrolment Process (REP) as of October 1, 2020 Date: July 6, 2020 Our file number: 20-1052634-535 By way of this update, Health Products and Food Branch (HPFB) is reminding sponsors that the mandatory date for use of the…
Les langues officielles aux IRSC Les Instituts de recherche en santé du Canada (IRSC) sont assujettis à la Loi sur les langues officielles . Ils sont donc appelés à offrir des services au public dans les deux langues officielles du Canada et à promouvoir l’épanouissement des…
Notice: Prescription Drug List (PDL): Multiple additions Date: July 15, 2020 Our file number: 20-109282-899 The purpose of this Notice of Amendment is to notify about the additions of Alpelisib, Baloxavir marboxil, Betula verrucosa (white birch), Brolucizumab, Cabotegravir,…
Statement on the classification of insulin products and duration of action: Notice to stakeholders Date published: August 6, 2020 Issue After conducting a class review of Product Monographs for various insulin products authorized in Canada over time, Health Canada has concluded…
Notice of Intent to Amend the Prescription Drug List: Vitamin D August 19, 2020 Our file number: 20-110519-351 The purpose of this Notice of Intent to Amend is to notify that the Prescription Drug List (PDL) qualifier for Vitamin D will be amended to allow non-prescription status…
Nitrosamine impurities in medications: Overview Overview Recalls Test methods and test results Guidance Established acceptable intake limits Report a problem or concern On this page What's new Background About nitrosamine impurities What we are doing Related links What's new…
Notice: Prescription Drug List (PDL): Multiple Additions Date: September 8, 2020 Our file number: 20-112398-776 The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate,…
Interim Order Respecting Drug Shortages (Safeguarding the Drug Supply) Whereas the Minister of Health believes that immediate action is required to deal with a significant risk to health, safety or the environment; Therefore, the Minister of Health, pursuant to subsection…
La mobilisation des connaissances aux IRSC Le mandat des IRSC comprend la mobilisation des connaissances (MC) comme façon d'améliorer la santé, d'offrir de meilleurs produits et services de santé, et de renforcer les systèmes de santé. Ce volet de leur mandat est essentiel, car…
Early release: coverage and features are still expanding.
